You still need to keep up with the healthy eating patterns and regular exercise
The SUSTAIN-6 Trial (Once-Weekly Semaglutide) The Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes (SUSTAIN-6) consisted of 3297 people living with T2DM, 83% with established cardiovascular disease, receiving once-weekly semaglutide (0.5 and 1.0 mg) or placebo
As Nooms data shows, engagement predicts successand the high level of engagement with Nooms GLP-1 Companion app demonstrates the power of Nooms behavior change program
As for erythromycin, it's important to consider its pharmacodynamic interaction with GLP-1RAs, as erythromycin counteracts GLP-1RAs effect on delaying gastric emptying and reduces its postprandial antihyperglycemic effect[50]
If you are the type of person who forgets to take daily medications, weekly injections are actually more forgiving
While the long half-life of semaglutide theoretically supports less frequent dosing, clinical data supports either daily oral or weekly injectable schedules
